4
Changes in Ownership
OCULAR THERAPEUTIX, INC Filed Acc 0001104659-25-053091
Chief Development Officer sold 2,974 shares at $7.17 ($21,324)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Kaiser Peter · Chief Development Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-05-23 | Sale : show line 1 in the form 10b5-1 | −2,974 | $7.17 | $21,324 | 207,104 | D |
| Open-market sales · 2,974 sh · avg $7.17 · $21,324 | ||||||
Loading xslF345X05/tm2516174-3_4seq1.xml…